Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-8-27
|
pubmed:abstractText |
The effects of coenzyme Q10(CoQ10) on exercise performance were studied in 12 patients, average age 56 years, with stable angina pectoris. The study involved a double-blind, placebo-controlled, randomized, crossover protocol, using multistage treadmill exercise tests. CoQ10(150 mg/day in 3 daily doses) was administered orally for 4 weeks, tended to reduce anginal frequency from 5.3 +/- 4.9 to 2.5 +/- 3.3 attacks for 2 weeks and nitroglycerin consumption from 2.6 +/- 2.8 to 1.3 +/- 1.7 tablets for 2 weeks compared with patients receiving the placebo, but the reduction was not statistically significant. Exercise time increased from 345 +/- 102 seconds with placebo to 406 +/- 114 seconds during CoQ10 treatment (p less than 0.05). The time until 1 mm of ST-segment depression occurred increased from 196 +/- 76 seconds with placebo to 284 +/- 104 seconds during CoQ10 treatment (p less than 0.01). During the exercise test, ST-segment depression, heart rate and pressure-rate product at the same and at the maximal workload showed no significant difference between patients after placebo and CoQ10 administration. The average CoQ10 plasma concentration increased from 0.95 +/- 0.48 microgram/ml to 2.20 +/- 0.98 microgram/ml after CoQ10 treatment. This increase was significantly related to the increase in exercise duration (r = 0.68, p less than 0.001). Only 1 patient had a loss of appetite, but continued therapy. This study suggests that CoQ10 is a safe and promising treatment for angina pectoris.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-51
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3927692-Aged,
pubmed-meshheading:3927692-Angina Pectoris,
pubmed-meshheading:3927692-Chronic Disease,
pubmed-meshheading:3927692-Coenzymes,
pubmed-meshheading:3927692-Double-Blind Method,
pubmed-meshheading:3927692-Electrocardiography,
pubmed-meshheading:3927692-Exercise Test,
pubmed-meshheading:3927692-Female,
pubmed-meshheading:3927692-Hemodynamics,
pubmed-meshheading:3927692-Humans,
pubmed-meshheading:3927692-Male,
pubmed-meshheading:3927692-Middle Aged,
pubmed-meshheading:3927692-Nitroglycerin,
pubmed-meshheading:3927692-Random Allocation,
pubmed-meshheading:3927692-Rest,
pubmed-meshheading:3927692-Ubiquinone
|
pubmed:year |
1985
|
pubmed:articleTitle |
Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|